Delivery Order SPE2DR25D2005-SPE2DR26FE6N9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,681.36 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials. This is a firm fixed-price contract with no set-aside designation, competitively awarded for delivery to the company's headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,833.28 on October 27, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with completion scheduled for October 28, 2025. The contract utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $8,586.16 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed out of the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,001.46 on October 27, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials, with completion scheduled for October 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a ceiling value of $150,240.98. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $5,273.97 delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price contract with no set-aside utilizes a delivery order mechanism and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $6,602.38 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with an ultimate completion date of August 18, 2025. The contract employs firm fixed pricing and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen's place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters....
- The Defense Logistics Agency awarded a $13,451.77 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitively awarded, firm fixed price contract has a completion date of July 31, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,917.25 for Ozempic 2 mg/dose (8 mg/3 mL) pharmaceutical supplies on October 31, 2025, with an ultimate completion date of November 3, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order for diabetes medication to support federal medical procurement needs. The work is to be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, which...
- The Defense Logistics Agency awarded a $23,564.75 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE6N9Delivery Order
The Defense Logistics Agency awarded a $5,607.47 delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials, with completion expected by November 12, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications to support military and veteran healthcare systems. As a major pharmaceutical vendor, the company has demonstrated capability to fulfill federal healthcare requirements through multiple competitive awards across diverse therapeutic domains. The larger IDC vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the DLA planning to establish new generation pharmaceutical prime vendor contracts potentially involving multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 11/10/25 |